Your browser is no longer supported. Please, upgrade your browser.
EBS Emergent BioSolutions Inc. monthly Stock Chart
EBS [NYSE]
Emergent BioSolutions Inc.
Index- P/E28.97 EPS (ttm)3.21 Insider Own2.90% Shs Outstand52.60M Perf Week-4.80%
Market Cap4.96B Forward P/E11.28 EPS next Y8.25 Insider Trans-15.52% Shs Float45.13M Perf Month-7.65%
Income170.30M PEG3.15 EPS next Q2.10 Inst Own87.60% Short Float4.85% Perf Quarter4.57%
Sales1.26B P/S3.94 EPS this Y-8.50% Inst Trans0.42% Short Ratio2.50 Perf Half Y39.76%
Book/sh22.79 P/B4.08 EPS next Y21.74% ROA7.20% Target Price112.29 Perf Year71.44%
Cash/sh5.05 P/C18.44 EPS next 5Y9.20% ROE15.50% 52W Range46.37 - 137.61 Perf YTD72.46%
Dividend- P/FCF25.55 EPS past 5Y-2.60% ROI4.80% 52W High-32.39% Beta1.38
Dividend %- Quick Ratio1.90 Sales past 5Y22.30% Gross Margin64.50% 52W Low100.65% ATR4.93
Employees1834 Current Ratio2.70 Sales Q/Q62.30% Oper. Margin20.90% RSI (14)34.34 Volatility3.98% 4.37%
OptionableYes Debt/Eq0.66 EPS Q/Q- Profit Margin13.50% Rel Volume0.73 Prev Close96.71
ShortableYes LT Debt/Eq0.63 EarningsNov 05 AMC Payout0.00% Avg Volume876.14K Price93.04
Recom1.90 SMA20-9.80% SMA50-15.60% SMA20013.10% Volume658,318 Change-3.79%
Sep-14-20Resumed JP Morgan Neutral $103
Jul-31-20Reiterated Chardan Capital Markets Buy $86 → $112
Sep-12-19Initiated Guggenheim Buy
Sep-04-19Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18Upgrade Goldman Neutral → Buy
Aug-03-18Reiterated Chardan Capital Markets Buy $53 → $57
Jun-13-18Initiated Argus Buy $62
Apr-25-18Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18Initiated Goldman Neutral
Jan-16-18Reiterated Chardan Capital Markets Buy $47 → $53
Jun-28-16Reiterated Singular Research Buy $44 → $40
Apr-15-16Initiated Chardan Capital Markets Buy $47
Mar-28-16Initiated Singular Research Buy $44
Feb-19-16Initiated Wells Fargo Outperform
May-15-14Initiated Summer Street Research Buy $35
May-31-11Reiterated WBB Securities Strong Buy $20.50 → $30
Jan-10-11Reiterated Wedbush Outperform $27 → $32
Nov-05-10Reiterated Wedbush Outperform $22 → $27
Aug-18-10Upgrade WBB Securities Buy → Strong Buy $20.50
Aug-06-10Reiterated Caris & Company Buy $25 → $23
Oct-21-20 11:30AM  
10:48AM  
Oct-20-20 10:26AM  
Oct-19-20 10:09AM  
10:05AM  
09:55AM  
Oct-16-20 09:58AM  
08:54AM  
Oct-15-20 05:45PM  
12:45PM  
10:24AM  
Oct-14-20 10:03AM  
Oct-13-20 12:31PM  
10:36AM  
10:32AM  
10:30AM  
09:47AM  
09:45AM  
08:30AM  
Oct-12-20 09:45AM  
08:50AM  
Oct-09-20 08:40AM  
08:32AM  
Oct-08-20 04:05PM  
11:37AM  
08:37AM  
Oct-07-20 10:49AM  
10:46AM  
Oct-06-20 09:19AM  
Oct-05-20 12:46PM  
11:30AM  
Sep-21-20 04:25AM  
Sep-18-20 11:30AM  
Sep-16-20 12:19PM  
Sep-15-20 10:48AM  
Sep-11-20 05:50PM  
Sep-10-20 12:11PM  
Sep-08-20 04:34AM  
Sep-04-20 11:41AM  
Sep-02-20 11:30AM  
09:55AM  
Sep-01-20 10:10AM  
Aug-31-20 06:30AM  
Aug-29-20 11:31AM  
Aug-26-20 01:33PM  
01:11PM  
12:23PM  
08:04AM  
06:30AM  
Aug-25-20 01:25PM  
Aug-24-20 12:45PM  
Aug-22-20 06:09AM  
Aug-18-20 12:39PM  
11:59AM  
06:31AM  
Aug-17-20 11:54AM  
11:30AM  
06:30AM  
Aug-13-20 09:11AM  
07:58AM  
Aug-12-20 09:26AM  
Aug-07-20 04:05PM  
11:44AM  
08:03AM  
08:00AM  
Aug-06-20 12:45PM  
10:34AM  
Aug-05-20 12:17PM  
Aug-04-20 10:22PM  
06:31PM  
05:33PM  
09:56AM  
08:00AM  
Aug-03-20 06:27PM  
Jul-31-20 03:26PM  
03:08PM  
02:04PM  
Jul-30-20 09:01PM  
04:27PM  
Jul-28-20 11:30AM  
07:19AM  
Jul-27-20 02:29PM  
09:14AM  
07:57AM  
07:18AM  
06:47AM  
06:30AM  
Jul-26-20 06:15AM  
Jul-24-20 05:45PM  
12:52PM  
Jul-23-20 11:36AM  
10:15AM  
Jul-21-20 04:45PM  
04:45PM  
12:45PM  
08:11AM  
Jul-20-20 06:36PM  
12:00PM  
11:36AM  
Jul-16-20 06:30AM  
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard a combination drug-device auto injector product candidate. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; and ADENOVIRUS 4/7. Further, the company offers other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan, and Lassa viruses; diarrheal disease caused by Shigella; and heat-labile toxin producing enterotoxigenic Escherichia coli, etc. Additionally, it offers FLU-IGIV to treat Influenza A infection; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract development and manufacturing services to pharma and biotech industries, and government agencies/non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
El-Hibri FuadChairmanSep 24Sale98.8512,5351,239,0851,123,988Sep 25 07:00 PM
El-Hibri FuadChairmanSep 23Sale100.5813,0001,307,5401,136,523Sep 25 07:00 PM
El-Hibri FuadChairmanSep 17Sale100.6820,0002,013,6001,149,523Sep 18 06:25 PM
El-Hibri FuadChairmanSep 16Sale102.4820,0002,049,6001,169,523Sep 18 06:25 PM
El-Hibri FuadChairmanSep 10Sale102.6620,0002,053,2001,189,523Sep 11 09:21 PM
El-Hibri FuadChairmanSep 09Sale102.8020,0002,056,0001,209,523Sep 11 09:21 PM
SULLIVAN LOUIS WDirectorSep 02Option Exercise20.087,893158,49150,655Sep 04 08:08 PM
SULLIVAN LOUIS WDirectorSep 02Sale111.2228,4183,160,60642,762Sep 04 08:08 PM
Bailey SueDirectorAug 18Sale128.314,665598,56432,595Aug 19 05:08 PM
Harsanyi ZsoltDirectorAug 17Sale133.716,609883,66424,579Aug 18 09:12 AM
JOULWAN GEORGE ADirectorAug 11Sale124.116,000744,63526,771Aug 12 04:52 PM
Zoon Kathryn CDirectorAug 10Sale130.271,000130,27012,489Aug 11 04:43 PM
Richard RonaldDirectorAug 07Sale131.006,297824,9078,276Aug 11 04:46 PM
Richard RonaldDirectorJun 03Sale87.516,572575,1424,269Jun 05 04:36 PM
Bailey SueDirectorJun 03Sale87.505,322465,69137,260Jun 05 04:33 PM
Hauer Jerome MDirectorMay 26Sale85.154,385373,37310,188May 27 05:10 PM
Zoon Kathryn CDirectorMay 26Sale85.104,093348,32213,489May 27 05:07 PM
Harsanyi ZsoltDirectorMay 14Option Exercise18.643,43464,01028,367May 18 07:12 PM
Zoon Kathryn CDirectorMay 12Sale85.211,660141,45414,761May 14 04:30 PM
Harsanyi ZsoltDirectorMay 11Sale81.994,940405,02524,933May 13 07:47 PM
JOULWAN GEORGE ADirectorMay 11Sale85.192,000170,37129,950May 13 07:45 PM
Richard RonaldDirectorMay 05Sale80.198,375671,6298,020May 06 05:08 PM
El-Hibri FuadChairmanApr 30Sale74.0120,0001,480,2001,229,523May 01 08:13 PM
El-Hibri FuadChairmanApr 29Sale74.2420,0001,484,8001,249,523May 01 08:13 PM
Richard RonaldDirectorApr 27Option Exercise20.087,893158,49124,288Apr 29 04:35 PM
Richard RonaldDirectorApr 27Sale78.007,893615,65416,395Apr 29 04:35 PM
El-Hibri FuadChairmanApr 23Sale68.4920,0001,369,8001,269,523Apr 24 04:16 PM
El-Hibri FuadChairmanApr 22Sale66.8120,0001,336,2001,289,523Apr 24 04:16 PM
Havey AdamEVP, Business OperationsApr 20Option Exercise30.8617,009524,89851,265Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 20Sale69.0017,0091,173,62134,256Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 17Option Exercise26.4520,414539,95054,670Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 17Sale65.0020,4141,326,91034,256Apr 21 06:12 PM
El-Hibri FuadChairmanApr 16Sale62.4720,0001,249,4001,309,523Apr 20 06:30 PM
El-Hibri FuadChairmanApr 15Sale62.5812,537784,5651,329,523Apr 15 09:04 PM
El-Hibri FuadChairmanApr 14Sale62.996,261394,3801,342,060Apr 15 09:04 PM
El-Hibri FuadChairmanApr 13Sale62.2517,0711,062,6701,348,321Apr 15 09:04 PM
El-Hibri FuadChairmanApr 09Sale61.8323,7161,466,3601,365,392Apr 10 07:13 PM
El-Hibri FuadChairmanApr 08Sale61.1337,3622,284,1151,389,108Apr 10 07:13 PM
El-Hibri FuadChairmanApr 07Sale60.7614,336871,0551,426,470Apr 08 09:17 PM
Kirk SeanEVP, Manufacturing & Tech OpsApr 06Option Exercise30.7010,428320,13119,864Apr 08 08:19 PM
El-Hibri FuadChairmanApr 06Sale60.5028,2401,708,5201,440,806Apr 08 09:17 PM
Havey AdamEVP, Business OperationsApr 06Sale60.007,972478,32034,256Apr 08 08:22 PM
Kirk SeanEVP, Manufacturing & Tech OpsApr 06Sale60.0016,094965,64012,571Apr 08 08:19 PM
Harsanyi ZsoltDirectorMar 16Sale65.006,400416,00029,873Mar 17 04:39 PM
SULLIVAN LOUIS WDirectorMar 04Option Exercise13.8615,786218,71568,359Mar 06 04:37 PM
Zoon Kathryn CDirectorMar 04Sale60.6599160,10316,421Mar 06 04:39 PM
SULLIVAN LOUIS WDirectorMar 04Sale58.9615,786930,71460,466Mar 06 04:37 PM
Bailey SueDirectorFeb 27Sale56.936,572374,13239,761Mar 02 05:28 PM
El-Hibri FuadChairmanFeb 27Sale56.979,837560,4141,469,046Feb 28 08:01 PM
El-Hibri FuadChairmanFeb 26Sale58.7013,619799,4351,472,943Feb 28 08:01 PM
El-Hibri FuadChairmanFeb 21Option Exercise25.6218,567475,6871,497,585Feb 24 08:00 PM
Richard RonaldDirectorFeb 21Option Exercise18.645,15296,03331,851Feb 25 04:30 PM
Richard RonaldDirectorFeb 21Sale65.005,152334,88016,395Feb 25 04:30 PM
Hauer Jerome MDirectorFeb 21Sale70.006,572460,04011,752Feb 25 04:28 PM
El-Hibri FuadChairmanFeb 21Sale64.9018,5671,204,9981,479,018Feb 24 08:00 PM
El-Hibri FuadChairmanFeb 20Option Exercise25.624,751121,7211,483,769Feb 24 08:00 PM
El-Hibri FuadChairmanFeb 20Sale64.904,751308,3401,479,018Feb 24 08:00 PM
El-Hibri FuadChairmanFeb 18Option Exercise25.6215,614400,0311,494,632Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 18Sale63.9015,614997,7351,479,018Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 14Option Exercise25.624,386112,3691,483,404Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 14Sale63.904,386280,2651,479,018Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 12Option Exercise25.6213,720351,5061,492,738Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 12Sale62.9013,720862,9881,479,018Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 11Option Exercise25.626,280160,8941,485,298Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 11Sale62.906,280395,0121,479,018Feb 13 06:30 PM
El-Hibri FuadExecutive ChairmanFeb 06Sale61.9011,684723,2401,419,018Feb 07 06:31 PM
El-Hibri FuadExecutive ChairmanFeb 05Sale60.6648,3162,930,8491,430,702Feb 07 06:31 PM
Harsanyi ZsoltDirectorJan 16Sale55.003,435188,92536,273Jan 17 04:19 PM
Bailey SueDirectorDec 12Sale53.468,375447,72846,333Dec 13 09:21 AM
Zoon Kathryn CDirectorNov 18Sale54.311,00054,31417,412Nov 19 04:11 PM
Zoon Kathryn CDirectorNov 08Sale54.153,082166,88418,412Nov 12 09:52 AM
Richard RonaldDirectorNov 07Option Exercise18.645,15396,05231,852Nov 12 09:51 AM
Richard RonaldDirectorNov 07Sale60.005,153309,18026,699Nov 12 09:51 AM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.